Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma of the gastroesophageal junction
|
6 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Arteriosclerosis
|
267 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 0.667 | 3 | 2008 | 2010 | ||||||
Atherogenic dyslipidaemia
|
9 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Atherosclerosis
|
281 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 0.667 | 3 | 2008 | 2010 | ||||||
Autoantibody measurement
|
52 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||
Autonomic neuropathy
|
7 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Birth Weight
|
369 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
Body mass index
|
2689 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.800 | 1.000 | 9 | 2012 | 2019 | ||||||
Breast Carcinoma
|
2793 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.060 | 1.000 | 6 | 2012 | 2018 | ||||||
Carcinoma of lung
|
1204 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Cardiovascular Diseases
|
711 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.060 | 0.833 | 6 | 2008 | 2017 | ||||||
Cerebrovascular accident
|
591 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2011 | 2014 | ||||||
Cholangiocarcinoma
|
43 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Chronic kidney disease stage 5
|
194 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Chronic Kidney Diseases
|
306 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 0.500 | 2 | 2008 | 2014 | ||||||
Colon Carcinoma
|
275 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2008 | ||||||
Colorectal Carcinoma
|
1962 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2008 | 2018 | ||||||
Constitutional obesity
|
3 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Coronary Arteriosclerosis
|
440 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2009 | ||||||
Coronary Artery Disease
|
1577 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2008 | 2011 | ||||||
Coronary heart disease
|
1178 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.720 | 1.000 | 3 | 2008 | 2011 | ||||||
Cystic Fibrosis
|
704 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Diabetes
|
710 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.100 | 1.000 | 35 | 2006 | 2020 | ||||||
Diabetes in youth
|
2 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Diabetes Mellitus
|
824 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.100 | 1.000 | 37 | 2006 | 2020 |